Susan Lu

2.1k total citations
42 papers, 1.6k citations indexed

About

Susan Lu is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Susan Lu has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 25 papers in Pulmonary and Respiratory Medicine and 18 papers in Immunology and Allergy. Recurrent topics in Susan Lu's work include Asthma and respiratory diseases (31 papers), Respiratory and Cough-Related Research (20 papers) and Allergic Rhinitis and Sensitization (18 papers). Susan Lu is often cited by papers focused on Asthma and respiratory diseases (31 papers), Respiratory and Cough-Related Research (20 papers) and Allergic Rhinitis and Sensitization (18 papers). Susan Lu collaborates with scholars based in United States, United Kingdom and Denmark. Susan Lu's co-authors include Theodore F. Reiss, Kerstin Malmström, Hendrik Nolte, Harold S. Nelson, David I. Bernstein, George Philip, Marie‐Pierre Malice, Bruce M. Prenner, Anjuli Nayak and Paul Chervinsky and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Susan Lu

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Lu United States 17 1.3k 889 751 272 159 42 1.6k
Gordon Raphael United States 16 677 0.5× 455 0.5× 343 0.5× 59 0.2× 115 0.7× 29 1.1k
William C. Howland United States 13 569 0.5× 385 0.4× 314 0.4× 81 0.3× 83 0.5× 19 871
P Godard France 17 681 0.5× 285 0.3× 482 0.6× 63 0.2× 151 0.9× 66 1.1k
Toshio Katsunuma Japan 21 616 0.5× 454 0.5× 274 0.4× 390 1.4× 265 1.7× 71 1.2k
R. M. Watson Canada 17 966 0.8× 405 0.5× 541 0.7× 44 0.2× 367 2.3× 20 1.2k
Stéphane Kirkesseli United States 11 851 0.7× 335 0.4× 466 0.6× 140 0.5× 354 2.2× 16 1.3k
Toshihiko Kaise Japan 16 254 0.2× 144 0.2× 200 0.3× 97 0.4× 143 0.9× 47 777
N. Hizawa Japan 23 641 0.5× 138 0.2× 554 0.7× 91 0.3× 325 2.0× 39 1.4k
Yasuo To Japan 18 566 0.4× 76 0.1× 553 0.7× 20 0.1× 218 1.4× 49 1.1k
Kazuko Mitsuta Japan 15 324 0.3× 133 0.1× 200 0.3× 36 0.1× 111 0.7× 22 517

Countries citing papers authored by Susan Lu

Since Specialization
Citations

This map shows the geographic impact of Susan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Lu more than expected).

Fields of papers citing papers by Susan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Lu. The network helps show where Susan Lu may publish in the future.

Co-authorship network of co-authors of Susan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Lu. A scholar is included among the top collaborators of Susan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Lu. Susan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birring, Surinder S., Linda Cardozo, Roger R. Dmochowski, et al.. (2024). Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine. 12(11). 855–864. 1 indexed citations
2.
Birring, SS, L. Cardozo, Peter V. Dicpinigaitis, et al.. (2023). S1 A phase 3b trial of gefapixant, a P2X3-receptor antagonist, in women with chronic cough and stress urinary incontinence. A5.1–A5. 1 indexed citations
3.
Birring, Surinder S., L. Cardozo, Roger R. Dmochowski, et al.. (2023). A Phase 3b Trial of Gefapixant, A P2X3-receptor Antagonist, in Women With Chronic Cough and Stress Urinary Incontinence. A1601–A1601. 1 indexed citations
4.
Birring, SS, L. Cardozo, Roger R. Dmochowski, et al.. (2020). A Phase 3b Trial Evaluating the Efficacy of Gefapixant in Reducing Stress Urinary Incontinence in Women with Chronic Cough. A7776–A7776. 1 indexed citations
5.
Nolte, Hendrik, et al.. (2018). Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet. The Journal of Allergy and Clinical Immunology In Practice. 6(6). 2081–2086.e1. 14 indexed citations
6.
Bernstein, David I., Jörg Kleine‐Tebbe, Harold S. Nelson, et al.. (2018). SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration. Annals of Allergy Asthma & Immunology. 121(1). 105–110. 12 indexed citations
7.
Nolte, Hendrik, Thomas B. Casale, Richard F. Lockey, et al.. (2016). Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets. The Journal of Allergy and Clinical Immunology In Practice. 5(1). 84–89.e3. 37 indexed citations
8.
Nolte, Hendrik, David I. Bernstein, Harold S. Nelson, et al.. (2016). Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 138(6). 1631–1638. 109 indexed citations
9.
Rennard, Stephen I., David C. Dale, James F. Donohue, et al.. (2015). CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 191(9). 1001–1011. 190 indexed citations
10.
Price, David, Todor A. Popov, Leif Bjermer, et al.. (2013). Effect of montelukast for treatment of asthma in cigarette smokers. Journal of Allergy and Clinical Immunology. 131(3). 763–771.e6. 55 indexed citations
11.
Lu, Susan, Marie‐Pierre Malice, Sairia Dass, & Theodore F. Reiss. (2009). Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis. Journal of Asthma. 46(9). 878–883. 19 indexed citations
12.
Lu, Susan, Nancy Liu, Sairia Dass, Theodore F. Reiss, & Barbara Knorr. (2009). Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma. Respiratory Medicine. 103(3). 342–347. 14 indexed citations
13.
Lu, Susan, Nancy Liu, Sairia Dass, & Theodore F. Reiss. (2009). A Randomized Study Comparing the Effect of Loratadine Added to Montelukast with Montelukast, Loratadine, and Beclomethasone Monotherapies in Patients with Chronic Asthma. Journal of Asthma. 46(5). 465–469. 6 indexed citations
14.
Kearns, Gregory L., Susan Lu, Xiujiang Li, et al.. (2008). Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis. The Journal of Clinical Pharmacology. 48(4). 502–511. 20 indexed citations
15.
Lu, Susan, et al.. (2006). An oral selective M3 cholinergic receptor antagonist in COPD. European Respiratory Journal. 28(4). 772–780. 15 indexed citations
16.
Baumgartner, Rudolf A., Jonathan M. Edelman, Gabriel Gómez, et al.. (2003). Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. European Respiratory Journal. 21(1). 123–128. 44 indexed citations
17.
Nayak, Anjuli, George Philip, Susan Lu, Marie‐Pierre Malice, & Theodore F. Reiss. (2002). Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Annals of Allergy Asthma & Immunology. 88(6). 592–600. 166 indexed citations
18.
Malmström, Kerstin, et al.. (2002). Quality assurance of asthma clinical trials. Controlled Clinical Trials. 23(2). 143–156. 24 indexed citations
19.
Noonan, Gertrude, et al.. (2001). Use of oral montelukast in the treatment of asthma. Comprehensive Therapy. 27(2). 148–155. 4 indexed citations
20.
Laviolette, Michel, Kerstin Malmström, Susan Lu, et al.. (1999). Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma. American Journal of Respiratory and Critical Care Medicine. 160(6). 1862–1868. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon Raphael Breakdown of academic impact, for papers by William C. Howland Breakdown of academic impact, for papers by P Godard Breakdown of academic impact, for papers by Toshio Katsunuma Breakdown of academic impact, for papers by R. M. Watson Breakdown of academic impact, for papers by Stéphane Kirkesseli Breakdown of academic impact, for papers by Toshihiko Kaise Breakdown of academic impact, for papers by N. Hizawa Breakdown of academic impact, for papers by Yasuo To Breakdown of academic impact, for papers by Kazuko Mitsuta
Rankless by CCL
2026